''Monitoring of research funding policy on Covid-19 in Brazil, 2020-2021 from an equity perspective.''
Health research; Research funding; research and technological development; COVID-19; Brazil.
Introduction: The rapid expansion of Covid-19 exacerbated the difficulties of establishing rapid and effective responses. There was an urgent need for investment, especially in scientific research, as a powerful tool in responding to emerging issues related to the disease, with measures capable of providing evidence on the most appropriate public policies and interventions to deal with the problems caused by the pandemic. Objective: Analyze interinstitutional collaboration between government institutions, national and state research support agencies and state health and science and technology departments to issue calls for COVID-19 research and technological development proposals in Brazil between 2020 and 2021, and examine the distribution of the number of studies and financial resources among the funded institutions in the states and regions of the country, as well as the topics studied and types of research financed. Methodology: A retrospective study with document analysis of national and state calls for Covid-19 research proposals issued between 2020 and 2021 and the results of the funding provided by government institutions and national and state research support agencies. Data were extracted regarding financial resources offered, the collaborating institutions affiliated with the calls, number of studies and the amount of funding received, nature of the funded institutions and the type of research funded. Data were collected from October 2021 to October 2022. Results: In 2020 and 2021, 55 research proposal calls were issued (PPP$ 249.50 million) through cooperation between 29 institutions. A total of 864 studies were funded across 257 Brazilian institutions, mainly public universities and private companies. The greatest mobilization of resources occurred in 2020 (PPP$ 196.91 million) through calls for research proposals (45). However, this did not accompany the country’s largest peak of COVID-19 cases and mortality. Biomedical and clinical research received the most funding. Conclusion: The results of the study reinforce the need to encourage scientific research in order to investigate the many questions raised by Covid-19. Collaboration between research support agencies in the country strengthen health systems, services and policies and contribute to responses to health emergencies. These combined efforts are important in defining, funding and monitoring Covid-19 research.